BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

969 related articles for article (PubMed ID: 8908505)

  • 1. In vitro sensitization of the B16 murine melanoma cells to ganciclovir by different RNA and plasmid DNA constructions encoding HSVtk.
    Yarovoi SV; Mouawad R; Colbère-Garapin F; Soubrane C; Khayat D; Rixe O
    Gene Ther; 1996 Oct; 3(10):913-8. PubMed ID: 8908505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer in hepatocarcinoma cell lines: in vitro optimization of a virus-free system.
    Ghoumari AM; Rixe O; Yarovoi SV; Zerrouqi A; Mouawad R; Poynard T; Opolon P; Khayat D; Soubrane C
    Gene Ther; 1996 Jun; 3(6):483-90. PubMed ID: 8789797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene.
    Kim YG; Bi W; Feliciano ES; Drake RR; Stambrook PJ
    Cancer Gene Ther; 2000 Feb; 7(2):240-6. PubMed ID: 10770632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.
    Zerrouqi A; Rixe O; Ghoumari AM; Yarovoi SV; Mouawad R; Khayat D; Soubrane C
    Cancer Gene Ther; 1996; 3(6):385-92. PubMed ID: 8988841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of HSVtk and connexin43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma.
    Ghoumari AM; Mouawad R; Zerrouqi A; Nizard C; Provost N; Khayat D; Naus CC; Soubrane C
    Gene Ther; 1998 Aug; 5(8):1114-21. PubMed ID: 10326035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase.
    Wei SJ; Chao Y; Hung YM; Lin WC; Yang DM; Shih YL; Ch'ang LY; Whang-Peng J; Yang WK
    Exp Cell Res; 1998 May; 241(1):66-75. PubMed ID: 9633514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
    Finocchiaro LM; Bumaschny VF; Karara AL; Fiszman GL; Casais CC; Glikin GC
    Cancer Gene Ther; 2004 May; 11(5):333-45. PubMed ID: 15107812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
    Smythe WR; Hwang HC; Amin KM; Eck SL; Davidson BL; Wilson JM; Kaiser LR; Albelda SM
    Cancer Res; 1994 Apr; 54(8):2055-9. PubMed ID: 8174104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells.
    Balzarini J; Degrève B; Andrei G; Neyts J; Sandvold M; Myhren F; de Clercq E
    Gene Ther; 1998 Mar; 5(3):419-26. PubMed ID: 9614564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system.
    Parada C; Hernández Losa J; Guinea J; Sánchez-Arévalo V; Fernández Soria V; Alvarez-Vallina L; Sánchez-Prieto R; Ramón y Cajal S
    Cancer Gene Ther; 2003 Feb; 10(2):152-60. PubMed ID: 12536204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-free transfer of the herpes simplex virus thymidine kinase gene followed by ganciclovir treatment induces tumor cell death.
    Calvez V; Rixe O; Wang P; Mouawad R; Soubrane C; Ghoumari A; Verola O; Khayat D; Colbère-Garapin F
    Clin Cancer Res; 1996 Jan; 2(1):47-51. PubMed ID: 9816089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.
    Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI
    Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation.
    Shibata MA; Morimoto J; Otsuki Y
    Cancer Gene Ther; 2002 Jan; 9(1):16-27. PubMed ID: 11916241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir.
    Prasmickaite L; Høgset A; Olsen VM; Kaalhus O; Mikalsen SO; Berg K
    Cancer Gene Ther; 2004 Jul; 11(7):514-23. PubMed ID: 15118758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C; Bergeron C; Lane D; Garon G; Piché A
    Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
    Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
    J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.